C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function: Report of an ADA Workshop, 21-22 October 2001

Jerry P. Palmer, G. Alexander Fleming, Carla J. Greenbaum, Kevan C. Herold, Lisa D. Jansa, Hubert Kolb, John M. Lachin, Kenneth S. Polonsky, Paolo Pozzilli, Jay S. Skyler, Michael W. Steffes

Research output: Contribution to journalArticlepeer-review

350 Scopus citations

Fingerprint Dive into the research topics of 'C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function: Report of an ADA Workshop, 21-22 October 2001'. Together they form a unique fingerprint.

Medicine & Life Sciences